NCT06934876 Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
| NCT ID | NCT06934876 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brian Driver |
| Condition | Acute Respiratory Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,092 participants |
| Start Date | 2025-04-21 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,092 participants in total. It began in 2025-04-21 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will compare the sensitivity and specificity of waveform capnography versus colorimetric carbon dioxide detection to identify tracheal placement of the endotracheal tube during intubation of critically ill adults.
Eligibility Criteria
Inclusion Criteria: 1. Patient is located in a participating unit (ED or ICU) 2. Patient is undergoing tracheal intubation. 3. The clinician intends to use an exhaled CO2 detection device to confirm tracheal placement of the tube. Exclusion Criteria: 1. Patient is known to be a prisoner 2. Patient is known to be \< 18 years old 3. A responsible clinician has determined that sole use of either waveform capnography or colorimetric testing is required for optimal care of the patient.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06934876 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Respiratory Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06934876 currently recruiting?
Yes, NCT06934876 is actively recruiting participants. Contact the research team at brian.driver@hcmed.org for enrollment information.
Where is the NCT06934876 trial being conducted?
This trial is being conducted at Chicago, United States, Burlington, United States, Minneapolis, United States, Saint Paul, United States and 5 additional locations.
Who is sponsoring the NCT06934876 clinical trial?
NCT06934876 is sponsored by Brian Driver. The trial plans to enroll 2,092 participants.